Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
Attridge, Jim
2006.
EQUITY OF ACCESS TO INNOVATIVE MEDICINES: MISSION IMPOSSIBLE?.
Economic Affairs,
Vol. 26,
Issue. 3,
p.
17.
Sikora, Karol
2007.
Paying for cancer care—a new dilemma.
Journal of the Royal Society of Medicine,
Vol. 100,
Issue. 4,
p.
166.
SIKORA, KAROL
2007.
DEVELOPMENT AND INNOVATION IN CANCER MEDICINE.
International Journal of Innovation Management,
Vol. 11,
Issue. 02,
p.
259.
Sikora, Karol
2007.
Top-up insurance for cancer drugs.
British Journal of Hospital Medicine,
Vol. 68,
Issue. 6,
p.
288.
Welsh, Sarah J.
and
Bch, BM
2008.
Targeted Cancer Therapy.
p.
411.
Sikora, Karol
2008.
Reforming cancer care.
Journal of Management & Marketing in Healthcare,
Vol. 1,
Issue. 2,
p.
127.
Welsh, Sarah J.
and
Powis, Garth
2008.
General Methods and Overviews, Lung Carcinoma and Prostate Carcinoma.
p.
93.
Johnson, AP
Abernathy, T
Howell, D
Brazil, K
and
Scott, S
2009.
Resource utilisation and costs of palliative cancer care in an interdisciplinary health care model.
Palliative Medicine,
Vol. 23,
Issue. 5,
p.
448.
Ferretti, Fabrizio
and
McIntosh, Bryan
2014.
Economic structural change and cancer incidence.
British Journal of Healthcare Management,
Vol. 20,
Issue. 6,
p.
275.
Skrepnek, Grant H.
2016.
Supportive Cancer Care.
p.
291.
Andreev, D. A.
Polyakova, K. I.
Zavyalov, A. A.
Ermolaeva, T. N.
Fisun, A. G.
Ermolaeva, A. D.
Dubovtseva, V. A.
and
Maksimova, T. E.
2020.
Crucial areas of the economic analysis of public cancer care.
FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology,
Vol. 12,
Issue. 4,
p.
310.